GURUFOCUS.COM » STOCK LIST » Financial Services » Diversified Financial Services » Soaring Eagle Acquisition Corp (NAS:SRNGW) » Definitions » Common Stock

Switch to:

Soaring Eagle Acquisition (Soaring Eagle Acquisition) Common Stock : $0.00 Mil (As of . 20)

View and export this data going back to 2021. Start your Free Trial

What is Soaring Eagle Acquisition Common Stock?

Soaring Eagle Acquisition Common Stock Historical Data

The historical data trend for Soaring Eagle Acquisition's Common Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Soaring Eagle Acquisition Common Stock Chart

Soaring Eagle Acquisition Annual Data

Trend

Dec20

Common Stock

-

Soaring Eagle Acquisition Semi-Annual Data
	Dec20
Common Stock	-

Soaring Eagle Acquisition Common Stock Calculation

Common stock is listed on the Balance Sheet at the par value of the total shares outstanding of a company.

The par value of common stocks is meaningless. It is usually set at an absurdly low number.

Soaring Eagle Acquisition (Soaring Eagle Acquisition) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Financial Services » Diversified Financial Services » Soaring Eagle Acquisition Corp (NAS:SRNGW) » Definitions » Common Stock

Comparable Companies

Traded in Other Exchanges

N/A

Address

955 Fifth Avenue, New York, NY, USA, 10075

Website

Soaring Eagle Acquisition Corp is a blank check company.

Soaring Eagle Acquisition (Soaring Eagle Acquisition) Headlines

From GuruFocus

Ginkgo Bioworks Provides First Half 2021 Update

By PRNewswire PRNewswire • 08-19-2021

Ginkgo Bioworks to Become a Public Company and Expand its Leading Platform for Cell Programming

By PRNewswire PRNewswire • 05-11-2021

Ginkgo Bioworks to Begin Trading Today as NYSE: DNA with Over $1.6 Billion in Proceeds

By PRNewswire PRNewswire • 09-17-2021

Ginkgo Bioworks and Soaring Eagle Acquisition Corp. Announce Effectiveness of Form S-4 Registration Statement

By PRNewswire PRNewswire • 08-11-2021

Ginkgo Bioworks' Ferment Consortium Launches Ayana Bio to Produce Plant and Fungal Bioactives for Herbal Medicines and Nutraceuticals

By PRNewswire PRNewswire • 09-09-2021

Cambium Biomaterials Announces Partnership with Ginkgo Bioworks to Accelerate Industrial Adoption of High-Performance Biomaterials

By PRNewswire PRNewswire • 09-02-2021

Antheia and Ginkgo Bioworks Announce Partnership to Accelerate Production of Essential Medicines using Synthetic Biology

By PRNewswire PRNewswire • 08-12-2021

INVESTOR ACTION NOTICE: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against Ginkgo Bioworks Holdings, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

By PRNewswire PRNewswire • 11-24-2021

Areion Asset Management Co Ltd Buys Soaring Eagle Acquisition Corp, SVF Investment Corp

By GuruFocus Research GuruFocus Editor • 08-03-2021

Soaring Eagle Announces Transfer of Listing to NYSE in Connection with its Proposed Business Combination with Ginkgo

By Business Wire Business Wire • 09-01-2021

Home About Jobs Site Map Term of Use Privacy Policy Mobile App Referral Program Partner Program FAQ Contact Us 中文 All-In-One Screener
Stock List Guru List Insider List Insider Trade Economic Indicators Industry Data DCF Calculator Discussion Board Plans Excel Add-In Google Sheets Add-on
© 2004-2024 GuruFocus.com, LLC. All Rights Reserved.
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.